Bio Saga Headlines

Bio Saga

Thursday, April 10, 2008

Biotech chief shifts investment focus

“We are changing the Merlin brand to reflect the move from early-stage biotechnology and our interest in the later stages of research,” Sir Christopher said.

The biotechnology sector was dealt another blow on Wednesday after Sir Christopher Evans, the biotechnology entrepreneur caught up in the cash-for-honours investigation, said he was starting a new investment firm that would not fund early-stage biotech companies.

Merlin Biosciences, the name of Sir Christopher’s venture capital firm known for providing much-needed seed funding to the industry, is being scrapped and its three funds are being transferred to a new company called Excalibur, which will provide services from venture capital to corporate finance and private equity.

for more details

No comments:

Life Science and Informatics

What is this?
is this a new industry?
or a old wine in a new bottle?

Well Life Sciences and Informatics can be anything form computational biology, all omes and omics, core bioinformatics to curation and literature mining, database creation, in the area of biology, chemistry , bio-chem space.

There are number of companies in India and bangalore is the forefront as a major bio-cluster with 20 to 30 companies in this sphere.

now how good are these companies doing?
how good are they in terms of the international markets and how profitable is their business?
what do they do?
their clients?

These are some interesting things that could be discussed in this blog page...

Tag It